Katie Smart
About Katie Smart
Katie Smart is a Senior Research Scientist at Exscientia, where she combines classical pharmacology with artificial intelligence to enhance drug design. She has a strong academic background with a PhD from the University of Warwick and has worked in various roles within the pharmaceutical industry.
Current Role at Exscientia
Katie Smart serves as a Senior Research Scientist at Exscientia, a position she has held since 2021. In this role, she focuses on integrating classical pharmacology with artificial intelligence to enhance drug design. She manages experimental logistics for various drug discovery projects, ensuring efficient operations and collaboration within her team.
Previous Experience at Exscientia
Prior to her current role, Katie worked at Exscientia as a Research Scientist from 2020 to 2021. During her time in this position, she contributed to the development of innovative approaches in drug discovery, leveraging her expertise in pharmacology and artificial intelligence.
Experience at Bicycle Therapeutics
Katie Smart held an Early Career Industry Fellowship at Bicycle Therapeutics for five months in 2019 to 2020. This experience allowed her to gain valuable insights into the biotechnology sector and further develop her skills in drug discovery and development.
Education and Academic Background
Katie Smart completed her Doctor of Philosophy (PhD) at the University of Warwick from 2016 to 2019. She also holds a Master of Science (MSc) from the University of Warwick, which she obtained from 2015 to 2016. Earlier, she earned a Bachelor of Science (BSc) in Medical Sciences from The University of Edinburgh, studying from 2011 to 2015. Her foundational education began at Langholm Academy, where she studied from 2005 to 2011.
Research Focus and Contributions
Katie combines classical pharmacology with artificial intelligence to improve drug design processes. She develops high-throughput cell-based GPCR screening platforms, which are essential for enhancing drug discovery. Her work contributes to advancing methodologies that facilitate the identification and development of new therapeutic agents.